Melhores Terapia com células T CAR Terapia com células T CAR em Israel - TOP-14 médicos

O Dr. Ron Ram realizou várias centenas de transplantes de células-tronco e publicou mais de 30 artigos científicos em hematologia e oncologia.

• Possui certificação do Conselho (Board-certified) em Medicina Interna, Hematologia e Oncologia Médica
• Treinamento de subespecialidade (Fellowship) no New York Medical College
• Especializa-se em malignidades hematológicas e transplantes
• Contribuinte acadêmico, incluindo autoria de capítulos de livros didáticos

O Dr. Ram Ron é especializado em terapia de células T CAR no Centro Médico Sourasky (Ichilov), trazendo vasta experiência para este tratamento avançado.

• Focado em terapias celulares de ponta
• Trabalha em um centro médico líder em oncologia
• Dedicado a abordagens de tratamento personalizadas

Chefe de Onco-Hematologia Pediátrica no Hospital Infantil Dana Dwek – A Dra. Ronit El Hasid é especializada em transplantes de medula óssea e sangue para crianças.

• Realizou mais de 300 procedimentos de transplante
• Publicou mais de 50 artigos médicos
• Apresentou pesquisas em mais de 40 conferências
• Membro (Fellow) da Associação Americana de Hematologia
• Treinamento no City of Hope Hospital em Los Angeles

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

O Dr. Michael Shapira é especialista em Transplante de Medula Óssea no Sourasky Medical Center (Ichilov), com vasta experiência na área.

• Formou-se pela Faculdade de Medicina da Universidade Hebraica em 1999
• Especializou-se em medicina interna no Hadassah Medical Center
• Médico sênior em Transplante de Medula Óssea no Hadassah
• Fluente em inglês e hebraico

Diretor de hemato-oncologia pediátrica no Centro Médico Sourasky – especialista em terapia com células T CAR para crianças com distúrbios sanguíneos e sarcomas.

• Pediatra sênior no Hospital Infantil Dana
• Treinado no Instituto Ortopédico Rizzoli – um dos centros líderes mundiais para câncer ósseo
• Membro da ISPHO – a associação israelense de hemato-oncologia pediátrica
• Coordena programas de tratamento de sarcomas para crianças

Com 31 anos de experiência, o Dr. Aviv é especialista em terapia com células T CAR no Centro Médico Sourasky (Clínica Ichilov).

• Foca-se exclusivamente em onco-hematologia
• Vasta experiência com terapias celulares avançadas
• Atende em um dos principais centros médicos de Israel

O Dr. Yair fez contribuições significativas para a hematologia, particularmente na leucemia linfocítica crônica, com inúmeros prêmios e pesquisas publicadas.

• Ganhador de múltiplos prêmios de prestígio, incluindo o Klitzberg Oncology Award
• Membro das Associações de Hematologia Israelense e Americana
• Treinamento extensivo em hematologia no Centro Médico de Tel Aviv
• Ativo em pesquisa com bolsas concedidas pela Fundação Científica Israelense (Israeli Science Foundation)

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.